Related Experiment Videos
Methylprednisolone therapy in laser injury of the retina
1Georgiana Dvorak Theobald Ophthalmic Pathology Laboratory, Department of Ophthalmology and Visual Sciences, Lions of Illinois Eye Research Institute, University of Illinois at Chicago, College of Medicine 60612.
Abstract:
The efficacy of methylprednisolone in argon-laser-induced retinal injury in primates was evaluated by clinical, histopathologic, and morphometric criteria. Methylprednisolone was given with a loading dose of 30 mg/kg followed by 5.4 mg/kg per hour in three different regimens: (1) starting 24 h before laser and continuing for 4 days; (2) starting immediately after laser and continuing for 4 days; and (3) starting immediately after laser and continuing for 8 h. Fundus photography, fluorescein angiography, and histologic examination showed significant beneficial effects of all three treatments compared to controls. Morphometrically, at the center of the lesion, the width of disrupted outer nuclear layer, the width of the affected RPE, and the percentage of residual photoreceptor nuclei confirmed the efficacies of treatment regimens 1 and 2, but not treatment regimen 3.
Insights
Methylprednisolone effectively treated argon-laser-induced retinal injury in primates. Regimens starting before or immediately after laser exposure for four days showed significant benefits, unlike shorter treatments.
Area of Science:
- Ophthalmology
- Pharmacology
- Retinal Research
Background:
- Argon-laser-induced retinal injury is a model for studying ocular damage.
- Methylprednisolone is a corticosteroid with anti-inflammatory properties.
Purpose of the Study:
- To evaluate the efficacy of methylprednisolone in treating laser-induced retinal injury in primates.
- To compare different methylprednisolone treatment regimens.
Main Methods:
- Primates with argon-laser-induced retinal injury received methylprednisolone via three different dosing regimens.
- Efficacy was assessed using clinical, histopathologic, and morphometric evaluations.
- Techniques included fundus photography, fluorescein angiography, and histologic examination.
Main Results:
- All three methylprednisolone treatment regimens demonstrated significant beneficial effects compared to controls.
- Morphometric analysis confirmed the efficacy of regimens initiated 24 hours pre-laser and immediately post-laser for four days.
- The regimen initiated immediately post-laser for only 8 hours was not confirmed as effective by morphometric analysis.
Conclusions:
- Methylprednisolone is effective in mitigating argon-laser-induced retinal injury in primates.
- Treatment timing and duration are critical for methylprednisolone efficacy.
- Regimens involving longer treatment durations (4 days) are more beneficial.